VinBrain Joint Stock Company radiology AI products

Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Which exact product, version and licensed modules are in the current offer?
Do related FDA submissions document the same scope, or different functions and versions?
Which costs, support obligations and local acceptance tests remain unresolved?

Prepare with a buyer guide:

Radiology AI pricing and total cost of ownership

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K241543

DrAid™ for Liver Segmentation

VinBrain Joint Stock Company

Authorized purpose: Support trained professionals in visualizing, evaluating, measuring, and reporting liver and physician-identified liver lesions on multiphase CT; it does not generate diagnoses or potential findings directly.

Modality: CT/CTA
Anatomy: Liver and physician-identified liver lesions.
Decision: 2024-12-06

Oncology quantification

FDA-cleared K221241

DrAid for Radiology v1

VinBrain Joint Stock Company

Authorized purpose: Passive PACS triage and notification for suspected pneumothorax in adult chest X-ray cases.

Modality: X-ray/Radiography
Anatomy: Chest/Lung
Decision: 2022-09-01

Acute triage and notification